Effects of various extraocular muscle enlargement patterns on muscle diameter index in graves ophthalmopathy patients: a retrospective cohort study.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
07 10 2023
07 10 2023
Historique:
received:
28
10
2022
accepted:
30
09
2023
medline:
1
11
2023
pubmed:
8
10
2023
entrez:
7
10
2023
Statut:
epublish
Résumé
Graves ophthalmopathy (GO) patients often undergo retrobulbar injection of glucocorticoids (GCs) as a common therapeutic approach. This study aimed to explore the impact of various patterns of extraocular muscle (EOM) enlargement on EOM changes following retrobulbar GCs injection in patients with GO. A retrospective analysis was conducted on GO patients who underwent retrobulbar GCs injections. Data pertaining to EOM diameter (EMD) and muscle diameter index (MDI) were collected from orbital computed tomography (CT) scans. The MDI change (ΔMDI) was calculated by comparing pre- and post-injection MDI values. The relationship between each pre EMD/MDI and ΔMDI was assessed using univariate and multivariate logistic regression analysis. A total of 68 patients with GO were included in this study, accounting for 118 eyes. After retrobulbar injections of GCs, 84 eyes showed a decrease in the MDI, while 34 eyes exhibited an increase in MDI. A threshold effect was observed in the relationship between medial pre EMD/MDI and ΔMDI. When the medial pre EMD/MDI was less than 0.28, a higher medial pre EMD/MDI was associated with a smaller ΔMDI (β = - 25.21, p = 0.0175). However, when the medial pre EMD/MDI was greater than 0.28, no significant association was found between pre EMD/MDI and ΔMDI. There was a negative correlation between medial + lateral pre EMD/MDI and ΔMDI (β = - 11.76, p < 0.0189). A higher medial + lateral pre EMD/MDI was associated with a greater decrease in MDI. Additionally, there was a positive correlation between superior rectus muscle-levator complex (SRLC) pre EMD/MDI and ΔMDI (β = 11.92, p = 0.040). The higher the value of SRLC pre EMD/MDI, the greater the ΔMDI. There was an association between pre EMD/MDI and changes in EOMs after retrobulbar injection of GCs in GO patients. In patients with predominantly enlarged medial rectus muscles and severe degrees of enlargement, retrobulbar injection of GCs should be assessed for its benefit; a combination of medial and lateral rectus muscle enlargement is beneficial for the shrinkage of EOMs following retrobulbar injections; the involvement of the SRLC rectus muscle may be a disadvantageous pattern of shrinkage of EOMs following retrobulbar injections.Trial registration This study is retrospectively registered. We have registered this study with the Chinese Clinical Trials Registry ( www.chictr.org.cn , registration number: ChiCTR2200063429).
Identifiants
pubmed: 37805656
doi: 10.1038/s41598-023-43942-w
pii: 10.1038/s41598-023-43942-w
pmc: PMC10560200
doi:
Substances chimiques
Glucocorticoids
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
16939Informations de copyright
© 2023. Springer Nature Limited.
Références
Bahn, R. S. Graves’ ophthalmopathy. New Engl. J. Med. 362(8), 726–38 (2010).
doi: 10.1056/NEJMra0905750
pubmed: 20181974
Dolman, P. J. Evaluating Graves’ orbitopathy. Best Pract. Res. Clin. Endocrinol. Metab. 26(3), 229–48 (2012).
doi: 10.1016/j.beem.2011.11.007
pubmed: 22632361
Tong, B. D., Xiao, M. Y., Zeng, J. X. & Xiong, W. MiRNA-21 promotes fibrosis in orbital fibroblasts from thyroid-associated ophthalmopathy. Mol. Vis. 21, 324–334 (2015).
pubmed: 25873777
Bijlsma, W. R. & Mourits, M. P. Radiologic measurement of extraocular muscle volumes in patients with Graves’ orbitopathy: a review and guideline. Orbit https://doi.org/10.1080/01676830600675319 (2006).
doi: 10.1080/01676830600675319
pubmed: 16754214
Bontzos, G. et al. Extraocular muscle volumetry for assessment of thyroid eye disease. J. Neuro-ophthalmol. Off. J. North Am. Neuro-Ophthalmol. Soc. https://doi.org/10.1097/WNO.0000000000001339 (2021).
doi: 10.1097/WNO.0000000000001339
Wiersinga, W. M., Regensburg, N. I. & Mourits, M. P. Differential involvement of orbital fat and extraocular muscles in graves’ ophthalmopathy. Eur. Thyr. J. 2(1), 14–21 (2013).
doi: 10.1159/000348246
Ebner, R., Devoto, M. H., Weil, D., Bordaberry, M. & Mir, C. Treatment of thyroid associated ophthalmopathy with periocular injections of triamcinolone. British J. Ophthalmol. 88(11), 1380–1386 (2004).
doi: 10.1136/bjo.2004.046193
Bagheri, A. et al. Intraorbital steroid injection for active thyroid ophthalmopathy. J. Ophthalm. Vis. Res. 15(1), 69–77 (2020).
Alkawas, Ayman A., Hussein, Atef M. & Shahien, Ezzat A. Orbital steroid injection versus oral steroid therapy in management of thyroid-related ophthalmopathy. Clin. Exper. Ophthalmol. 38(7), 692–697 (2010).
doi: 10.1111/j.1442-9071.2010.02332.x
Wang, Y. J., Du, B. X., Yang, M., Zhu, Y. Y. & He, W. M. Peribulbar injection of glucocorticoids for thyroid-associated ophthalmopathy and factors affecting therapeutic effectiveness: A retrospective cohort study of 386 cases. Exper. Therapeut. Med. 20(3), 2031–2038 (2020).
Chan, L. L., Tan, H. E., Fook, C. S., Teo, T. H. & Lim, L. H. Graves ophthalmopathy: the bony orbit in optic neuropathy, its apical angular capacity, and impact on prediction of risk. AJNR Am. J. Neuroradiol. 30(3), 597–602 (2009).
doi: 10.3174/ajnr.A1413
pubmed: 19147718
pmcid: 7051464
Szucs-Farkas, Z. et al. Using morphologic parameters of extraocular muscles for diagnosis and follow-up of Graves’ ophthalmopathy: diameters, areas, or volumes? AJR. Am. J. Roentgenol. 179(4), 1005–10 (2002).
doi: 10.2214/ajr.179.4.1791005
Hallin, E. S. & Feldon, S. E. Graves’ ophthalmopathy: I. Simple CT estimates of extraocular muscle volume. British J. Ophthalmol. 72(9), 674–7 (1988).
doi: 10.1136/bjo.72.9.674
Weis, E. et al. Quantitative computed tomographic predictors of compressive optic neuropathy in patients with thyroid orbitopathy: A volumetric analysis. Ophthalmology 119(10), 2174–2178 (2012).
doi: 10.1016/j.ophtha.2012.04.021
pubmed: 22709420
Berger, M. et al. Imaging of the medial rectus muscle predicts the development of optic neuropathy in thyroid eye disease. Sci. Rep. 12(1), 6259 (2022).
doi: 10.1038/s41598-022-10043-z
pubmed: 35428798
pmcid: 9012828
Nugent, R. A., Belkin, R. I., Neigel, J. M., Rootman, J. & Robertson, W. D. Graves orbitopathy: correlation of CT and clinical findings. Radiology 177(3), 675–682 (1990).
doi: 10.1148/radiology.177.3.2243967
pubmed: 2243967
Yang, M., Du, B. X., Wang, Y. J. & He, W. M. Clinical analysis of 2 170 cases of thyroid-associated ophthalmopathy involving extraocular muscles. J. Sichuan Univ. Med. Sci. Ed. 52(3), 510–515 (2021).
Murakami, Y., Kanamoto, T., Tsuboi, T., Maeda, T. & Inoue, Y. Evaluation of extraocular muscle enlargement in dysthyroid ophthalmopathy. Nippon Ganka Gakkai Zasshi 104(1), 34–38 (2000).
pubmed: 10659624
Haładaj, R. Comparison of lateral and medial rectus muscle in human: an anatomical study with particular emphasis on morphology, intramuscular innervation pattern variations and discussion on clinical significance. Surg. Radiol. Anatomy SRA 42(5), 607–616 (2020).
doi: 10.1007/s00276-019-02400-x
pubmed: 31897658
Haładaj, R. Normal anatomy and anomalies of the rectus extraocular muscles in human: A review of the recent data and findings. BioMed Res. Int. 2019, 8909162 (2019).
doi: 10.1155/2019/8909162
pubmed: 31976329
pmcid: 6954479